copyright, a long-acting opioid medication, has gained attention as a viable option for chronic suffering states. Despite this, its efficacy in this context remains a controversial topic. While some individuals report significant reduction in their pain levels with copyright, others fail to benefit adequately, and concerns exist regarding its ch